3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
NET
8
Gastrointestinal
8
Endocrine
8
Lymphoid
2
CNS
2
Sarcoma
1
Conditions
Sarcoma
200
Osteosarcoma
74
Sarcoma, Ewing
50
Rhabdomyosarcoma
48
Melanoma
42
Neuroblastoma
38
Gastrointestinal Stromal Tumors
35
Neoplasms
34
Neoplasm Metastasis
32
Bone Neoplasms
32
Colorectal Neoplasms
31
Glioblastoma
29
Breast Neoplasms
25
Ovarian Neoplasms
24
Wilms Tumor
23
Rhabdoid Tumor
23
Gliosarcoma
23
Glioma
23
Liposarcoma
22
Carcinoma, Non-Small-Cell Lung
22
Lymphoma, Non-Hodgkin
21
Sarcoma, Kaposi
20
Neurofibrosarcoma
20
Carcinoma, Renal Cell
20
Pancreatic Neoplasms
19
Medulloblastoma
19
Hepatoblastoma
19
Desmoid Tumors
18
Thyroid Neoplasms
17
Lymphoma
17
Interventions
amino-acid, glucose, and electrolyte solution
1
177Lu-octreotide, DOTA(0)-Tyr(3)-
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Gastro-enteropancreatic neuroendocrine tumor
×
Sarcoma
×
90 days
×
Clear all
NCT06441331
2026-05-01
KinLET
ITM Solucin GmbH
Phase 1
Recruiting
20 enrolled